Search CommunityWalk:


MacroGenics Inc.

1500 East Gude Drive
Rockville, MD 20850, USA

Category: Pharmaceutical

Used in the following map:

Maryland Biotech Industry Map

MacroGenics Inc., is engaged in the discovery, development and delivery of the novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases. The company was founded in 2000 with a mission to deliver life-changing medicines to patients.

MacroGenics' novel product candidates leverage its fully-integrated capabilities around the discovery, development, and production of antibodies and incorporate three proprietary technology platforms: Dual-Affinity Re-Targeting (DART) platform enables to design candidate therapeutics that target multiple disease-causing cells or redundant disease-associated pathways with a single molecule; Cancer Stem Cell platform provides new approaches to target cancers unresponsive to current therapy; and Fc Optimization platform enhances the natural immune system's ability to mediate killing of cancer cells.

MacroGenics has a diverse portfolio of product candidates focused in three therapeutic areas: autoimmune disorders, oncology and infectious diseases. Its product folio includes: DART mAb for Inflammation; MGAH22 (HER2) for Breast, other Solid Tumors; DART mAb for Multiple Solid Tumors; MGAWN1 for West Nile Virus etc.

MacroGenics has collaborations with Green Cross Corporation, National Institutes of Health, Eli Lilly & Co, Juvenile Diabetes Research Foundation International, OriGene Technologies, Inc., Neose Technologies Inc, Genzyme Corporation, Tufts University, etc. Its investors include: TPG Ventures, Alta Partners, InterWest, MPM Capital, CDP Ventures West, OrbiMed, etc.